leadf
logo-loader
viewAgraFlora Organics International Inc.

AgraFlora says Farmako subsidiary secures added supply of EU-GMP certified medical cannabis from ZenPharm

The company said the agreement will facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany over a three-year term

AgraFlora Organics International Inc. - AgraFlora subsidiary Farmako secures added supply of EU-GMP certified medical cannabis from ZenPharm
Farmako CEO Katrin Eckmans said it is the compnay's intention to establish partnerships with "reliable suppliers and ensure high quality and sustainable supply at a fair price range to German patients"

AgraFlora Organics International Inc (CSE:AGRA) (OCTMKTS:AGFAF) said on Tuesday that its subsidiary Farmako GmbH has executed a binding supply agreement with ZenPharm Limited, a subsidiary of Zenabis Global Inc (TSX:ZENA), to secure additional medical cannabis stock.

As result of the supply agreement, ZenPharm will supply EU Good Manufacturing Practice (GMP) quality medical cannabis flower cultivated by Zenabis to Farmako for distribution to medical cannabis patients in Germany. The agreement will facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany over a three-year term, said the company.

Farmako will distribute the products to its established network of German pharmacies and the products will carry Farmako’s branding, a key step in building “brand awareness and loyalty” with physicians, pharmacists and patients, noted the company. The products initially include high potency THC flower and balanced THC and CBD flower, two product categories that management believes are in highest demand in Germany. Shipments to Farmako are expected to start in November 2020.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

In a statement, Farmako CEO Katrin Eckmans said: “It is our intention to establish partnerships with reliable suppliers and ensure high quality and sustainable supply at a fair price range to German patients.”

She added: “ZenPharm and Zenabis have proven themselves as trustful and reliable supply partners. Our goal to provide sustainable product for German patients takes a big step forward with this transaction, and my team."

Germany’s medical cannabis market has a value of over EUR 170 million and saw more than 140,000 cannabis prescriptions issued in 2019.

Contact the author Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive

Quick facts: AgraFlora Organics International Inc.

Price: 0.025 CAD

CSE:AGRA
Market: CSE
Market Cap: $41.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of AgraFlora Organics International Inc. named herein, including the promotion by the Company of AgraFlora Organics International Inc. in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: AgraFlora Organics receives Health Canada cultivation...

AgraFlora Organics (CSE: AGRA-OTCPK: AGFAF) Chairman and CEO Brandon Boddy joined Steve Darling from Proactive Vancouver with news the company has received a cultivation license from Health Canada for their delta facility. That facility is the 2nd largest in Canada. Boddy telling Proactive...

on 05/19/2020

2 min read